Cargando…

ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto α-dystroglycan

Mutations in genes required for the glycosylation of α-dystroglycan lead to muscle and brain diseases known as dystroglycanopathies. However, the precise structure and biogenesis of the assembled glycan are not completely understood. Here we report that three enzymes mutated in dystroglycanopathies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gerin, Isabelle, Ury, Benoît, Breloy, Isabelle, Bouchet-Seraphin, Céline, Bolsée, Jennifer, Halbout, Mathias, Graff, Julie, Vertommen, Didier, Muccioli, Giulio G., Seta, Nathalie, Cuisset, Jean-Marie, Dabaj, Ivana, Quijano-Roy, Susana, Grahn, Ammi, Van Schaftingen, Emile, Bommer, Guido T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873967/ https://www.ncbi.nlm.nih.gov/pubmed/27194101 http://dx.doi.org/10.1038/ncomms11534

Ejemplares similares

ISPD Overexpression Enhances Ribitol-Induced Glycosylation of α-Dystroglycan in Dystrophic FKRP Mutant Mice
por: Cataldi, Marcela P., et al.
Publicado: (2019)

CDP-ribitol prodrug treatment ameliorates ISPD-deficient muscular dystrophy mouse model
por: Tokuoka, Hideki, et al.
Publicado: (2022)

The promiscuous binding pocket of SLC35A1 ensures redundant transport of CDP-ribitol to the Golgi
por: Ury, Benoît, et al.
Publicado: (2021)

Ribitol restores functionally glycosylated α-dystroglycan and improves muscle function in dystrophic FKRP-mutant mice
por: Cataldi, Marcela P., et al.
Publicado: (2018)

NAD+ enhances ribitol and ribose rescue of α-dystroglycan functional glycosylation in human FKRP-mutant myotubes
por: Ortiz-Cordero, Carolina, et al.
Publicado: (2021)

Crystal structures of fukutin-related protein (FKRP), a ribitol-phosphate transferase related to muscular dystrophy
por: Kuwabara, Naoyuki, et al.
Publicado: (2020)

Ribitol enhances matriglycan of α-dystroglycan in breast cancer cells without affecting cell growth
por: Lu, Pei J., et al.
Publicado: (2020)

Ribitol in Solution Is an Equilibrium of Asymmetric Conformations
por: Ohno, Shiho, et al.
Publicado: (2021)

The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition
por: Praissman, Jeremy L, et al.
Publicado: (2016)

Muscular Dystrophy with Ribitol-Phosphate Deficiency: A Novel Post-Translational Mechanism in Dystroglycanopathy
por: Kanagawa, Motoi, et al.
Publicado: (2017)

Metabolic Reprogramming by Ribitol Expands the Therapeutic Window of BETi JQ1 against Breast Cancer
por: Doddapaneni, Ravi, et al.
Publicado: (2023)

Whole Exome Sequencing Reveals DYSF, FKTN, and ISPD Mutations in Congenital Muscular Dystrophy Without Brain or Eye Involvement
por: Ceyhan-Birsoy, Ozge, et al.
Publicado: (2015)

Genomic characterization of ribitol teichoic acid synthesis in Staphylococcus aureus: genes, genomic organization and gene duplication
por: Qian, Ziliang, et al.
Publicado: (2006)

Effect of Ribitol and Plant Hormones on Aposymbiotical Growth of the Lichen-forming Fungi of Ramalina farinacea and Ramalina fastigiata
por: Wang, Yi, et al.
Publicado: (2009)

Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycan
por: Roscioli, Tony, et al.
Publicado: (2012)

Compound Heterozygous FKTN Variants in a Patient with Dilated Cardiomyopathy Led to an Aberrant α-Dystroglycan Pattern
por: Gaertner, Anna, et al.
Publicado: (2022)

Purification and characterization of a novel medium-chain ribitol dehydrogenase from a lichen-associated bacterium Sphingomonas sp.
por: Tran, Kiet N., et al.
Publicado: (2020)

Ribitol-Containing Wall Teichoic Acid of Tetragenococcus halophilus Is Targeted by Bacteriophage phiWJ7 as a Binding Receptor
por: Wakinaka, Takura, et al.
Publicado: (2022)

Ribitol alters multiple metabolic pathways of central carbon metabolism with enhanced glycolysis: A metabolomics and transcriptomics profiling of breast cancer
por: Tucker, Jason Driver, et al.
Publicado: (2022)

ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome
por: Willer, Tobias, et al.
Publicado: (2012)

SUZ domain–containing proteins have multiple effects on nonsense-mediated decay target transcripts
por: Halbout, Mathias, et al.
Publicado: (2023)

Downregulation of dystroglycan glycosyltransferases LARGE2 and ISPD associate with increased mortality in clear cell renal cell carcinoma
por: Miller, Michael R., et al.
Publicado: (2015)

Glucose/Ribitol Dehydrogenase and 16.9 kDa Class I Heat Shock Protein 1 as Novel Wheat Allergens in Baker’s Respiratory Allergy
por: Olivieri, Mario, et al.
Publicado: (2022)

Distinct expression of functionally glycosylated alpha-dystroglycan in muscle and non-muscle tissues of FKRP mutant mice
por: Blaeser, Anthony, et al.
Publicado: (2018)

Ribitol dose-dependently enhances matriglycan expression and improves muscle function with prolonged life span in limb girdle muscular dystrophy 2I mouse model
por: Wu, Bo, et al.
Publicado: (2022)

Phosphoglycolate has profound metabolic effects but most likely no role in a metabolic DNA response in cancer cell lines
por: Gerin, Isabelle, et al.
Publicado: (2019)

Parkinson's disease protein PARK7 prevents metabolite and protein damage caused by a glycolytic metabolite
por: Heremans, Isaac P., et al.
Publicado: (2022)

The synthesis of branched-chain fatty acids is limited by enzymatic decarboxylation of ethyl- and methylmalonyl-CoA
por: Dewulf, Joseph P., et al.
Publicado: (2019)

Overexpression of Mutant FKRP Restores Functional Glycosylation and Improves Dystrophic Phenotype in FKRP Mutant Mice
por: Tucker, Jason D., et al.
Publicado: (2018)

ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment
por: Li, Philip Kam-Tao, et al.
Publicado: (2016)

Zebrafish models for human FKRP muscular dystrophies
por: Kawahara, Genri, et al.
Publicado: (2010)

Status report of the HARP-CDP group
por: Bolshakova, A, et al.
Publicado: (2007)

A missense mutation in ISPD contributes to maintain muscle fiber stability
por: Guo, Lijin, et al.
Publicado: (2022)

Noncoding genetic variation in ISPD distinguishes gamecocks from nongame chickens
por: Bendesky, Andres, et al.
Publicado: (2023)

AGPAT2 interaction with CDP-diacylglycerol synthases promotes the flux of fatty acids through the CDP-diacylglycerol pathway
por: Mak, Hoi Yin, et al.
Publicado: (2021)

Green synthesis of 1,5-dideoxy-1,5-imino-ribitol and 1,5-dideoxy-1,5-imino-dl-arabinitol from natural d-sugars over Au/Al(2)O(3) and SO(4)(2−)/Al(2)O(3) catalysts
por: Gao, Hongjian, et al.
Publicado: (2021)

2008 Status Report of the HARP-CDP group
por: Bolshakova, A, et al.
Publicado: (2008)

Functional Roles of O-Glycosylation
por: Breloy, Isabelle, et al.
Publicado: (2018)

Cardiomyopathy in limb girdle muscular dystrophy R9, FKRP related
por: Libell, Eric M., et al.
Publicado: (2020)

FKRP-dependent glycosylation of fibronectin regulates muscle pathology in muscular dystrophy
por: Wood, A. J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6bvkj5438t22nkpvqg75r05g0s